| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.2 | 0.0006 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.19 | 0.0008 |